The mutation of the CALR gene on exon 9 of chromosome 19 is found in up to 25% of cases of ET or MF; this mutation indirectly stimulates the JAK-STAT pathway, increasing MPL activity in hematopoietic stem cells with consequent thrombocytosis. The gene discussed is SOAT1; the disease is essential thrombocythemia.